Home LiteratureArticle Details
PMID: 19538319 Published · ppublish English Journal Article Review

Epithelial tight junctions in intestinal inflammation.

Annals of the New York Academy of Sciences ·Vol. 1165 ·2009-05-00 ·Pages 294-300

Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M

Abstract

The epithelium in inflamed intestinal segments of patients with Crohn's disease is characterized by a reduction of tight junction strands, strand breaks, and alterations of tight junction protein content and composition. In ulcerative colitis, epithelial leaks appear early due to micro-erosions resulting from upregulated epithelial apoptosis and in addition to a prominent increase of claudin-2. Th1-cytokine effects by interferon-gamma in combination with TNFalpha are important for epithelial damage in Crohn's disease, while interleukin-13 (IL-13) is the key effector cytokine in ulcerative colitis stimulating apoptosis and upregulation of claudin-2 expression. Focal lesions caused by apoptotic epithelial cells contribute to barrier disturbance in IBD by their own conductivity and by confluence toward apoptotic foci or erosions. Another type of intestinal barrier defect can arise from alpha-hemolysin harboring E. coli strains among the physiological flora, which can gain pathologic relevance in combination with proinflammatory cytokines under inflammatory conditions. On the other hand, intestinal barrier impairment can also result from transcellular antigen translocation via an initial endocytotic uptake into early endosomes, and this is intensified by proinflammatory cytokines as interferon-gamma and may thus play a relevant role in the onset of IBD. Taken together, barrier defects contribute to diarrhea by a leak flux mechanism (e.g., in IBD) and can cause mucosal inflammation by luminal antigen uptake. Immune regulation of epithelial functions by cytokines may cause barrier dysfunction not only by tight junction impairments but also by apoptotic leaks, transcytotic mechanisms, and mucosal gross lesions.

MeSH Terms
Animals Apoptosis Colitis, Ulcerative/metabolism Crohn Disease/metabolism Epithelium/metabolism Humans Inflammatory Bowel Diseases/metabolism,pathology Interleukin-13/metabolism Intestinal Mucosa/metabolism,pathology Tight Junctions/metabolism
Chemicals
Interleukin-13
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Schulzke Joerg D
Department of General Medicine & Pathophysiology of Enteral Nutrition, Charité, Campus Benjamin Franklin, Berlin, Germany. joerg.schulzke@charite.de
Ploeger Svenja
Amasheh Maren
Fromm Anja
Zeissig Sebastian
Troeger Hanno
Richter Jan
Bojarski Christian
Schumann Michael
Fromm Michael
Article Info
Journal
Annals of the New York Academy of Sciences
Abbr.
Ann N Y Acad Sci
ISSN
1749-6632
Published
2009-05-00
Pages
294-300
Language
English
Region
United States
NLM ID
7506858
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com